Inventor · disambiguated record
William D. Thomas
Also filed as: THOMAS JR WILLIAM D · THOMAS WILLIAM · THOMAS WILLIAM D · THOMAS WILLIAM D JR
41 granted patents·17 pending applications·591 citations·filing 1995–2024
98Inventor score
Files withUNIV MASSACHUSETTS11CHEMOCENTRYX INC6MERCK SHARP & DOHME6PHARMACYCLICS LLC5AMBROSINO DONNA M4
Top patents by PatentIndex Score
58 records- 0196US7625559B2Antibodies against Clostridium difficile toxins and uses thereofUNIV MASSACHUSETTS·Filed 2005·Granted Dec 1, 2009·47 cites·4 claims
- 0295US7718683B2Triazolyl phenyl benzenesulfonamidesCHEMOCENTRYX INC·Filed 2007·Granted May 18, 2010·39 cites·4 claims
- 0394US8257709B2Antibodies against Clostridium difficile toxins and uses thereofAMBROSINO DONNA M·Filed 2009·Granted Sep 4, 2012·22 cites·23 claims
- 0494US6969520B2Active immunization against clostridium difficile diseaseACAMBIS INC·Filed 2003·Granted Nov 29, 2005·71 cites·6 claims
- 0593US7807704B2Bicyclic, nitrogen-containing compounds modulating CXCR4 and/or CCXCKR2CHEMOCENTRYX INC·Filed 2007·Granted Oct 5, 2010·30 cites·18 claims
- 0693US6680168B2Passive immunization against clostridium difficile diseaseACAMBIS INC·Filed 2001·Granted Jan 20, 2004·54 cites·2 claims
- 0792US10221146B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Mar 5, 2019·6 cites·18 claims
- 0892US9809561B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·8 cites·16 claims
- 0992US9657033B2Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2013·Granted May 23, 2017·20 cites·44 claims
- 1092US9266827B2Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2013·Granted Feb 23, 2016·23 cites·52 claims
- 1192US8236311B2Antibodies against clostridium difficile toxins and uses thereofAMBROSINO DONNA M·Filed 2009·Granted Aug 7, 2012·15 cites·25 claims
- 1290US9512111B2N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of diseaseGLICK GARY D·Filed 2011·Granted Dec 6, 2016·21 cites·15 claims
- 1390US7776877B2N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamidesCHEMOCENTRYX INC·Filed 2008·Granted Aug 17, 2010·11 cites·6 claims
- 1487US10774045B2Compounds for modulating mitochondrial functionMAYO FOUND MEDICAL EDUCATION & RES·Filed 2019·Granted Sep 15, 2020·2 cites·18 claims
- 1587US10377768B2Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Aug 13, 2019·6 cites·28 claims
- 1687US6214341B1Passive immunization against Clostridium difficile diseaseORAVAX INC·Filed 1998·Granted Apr 10, 2001·78 cites·10 claims
- 1785US8226952B2Human antibodies against rabies and uses thereofTHOMAS JR WILLIAM D·Filed 2010·Granted Jul 24, 2012·9 cites·23 claims
- 1885US7727532B2Human antibodies against rabies and uses thereofUNIV MASSACHUSETTS·Filed 2007·Granted Jun 1, 2010·6 cites·26 claims
- 1984US11161814B2Compounds for modulating mitochondrial functionMAYO FOUND MEDICAL EDUCATION & RES·Filed 2020·Granted Nov 2, 2021·1 cites·17 claims
- 2083US8609111B2Antibodies against clostridium difficile toxins and uses thereofAMBROSINO DONNA M·Filed 2012·Granted Dec 17, 2013·4 cites·30 claims
- 2180US9217029B2Antibodies against clostridium difficile toxins and uses thereofUNIV MASSACHUSETTS·Filed 2013·Granted Dec 22, 2015·2 cites·25 claims
- 2280US5919463AClostridium difficle toxins as mucosal adjuvantsORAVAX INC·Filed 1995·Granted Jul 6, 1999·65 cites·21 claims
- 2379US10336700B2Compounds for modulating mitochondrial functionMAYO FOUND MEDICAL EDUCATION & RES·Filed 2016·Granted Jul 2, 2019·2 cites·16 claims
- 2479US9382246B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2014·Granted Jul 5, 2016·2 cites·20 claims
- 2577US9409909B2N-(2-(hetaryl)aryl)arylsulfonamides and N-(2-(hetaryl)hetaryl)arylsulfonamidesCHEMOCENTRYX INC·Filed 2014·Granted Aug 9, 2016·2 cites·14 claims
- 2677US8153818B2Triazolyl phenyl benzenesulfonamidesCHARVAT TREVOR T·Filed 2010·Granted Apr 10, 2012·3 cites·23 claims
- 2775US9656988B2Inhibitors of Bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2016·Granted May 23, 2017·1 cites·19 claims
- 2875US7396914B2SARS nucleic acids, proteins, antibodies, and uses thereofUNIV MASSACHUSETTS·Filed 2004·Granted Jul 8, 2008·6 cites·12 claims
- 2975US2021269511A1Antibodies against clostridium difficile toxins and uses thereofUNIV MASSACHUSETTS·Filed 2020·Application pending·0 cites
- 3075US2025051306A1Ras inhibitorsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 3174US12017992B2Compounds for modulating mitochondrial functionMAYO FOUND MEDICAL EDUCATION & RES·Filed 2021·Granted Jun 25, 2024·0 cites·17 claims
- 3272US8551484B2Human antibodies against hepatitis C virus (HCV) and uses thereofAMBROSINO DONNA M·Filed 2008·Granted Oct 8, 2013·1 cites·18 claims
- 3371US9226956B2Immunization against Clostridium difficile diseaseTHOMAS JR WILLIAM D·Filed 2012·Granted Jan 5, 2016·1 cites·16 claims
- 3469US8481579B2Triazolyl phenyl benzenesulfonamidesCHARVAT TREVOR T·Filed 2012·Granted Jul 9, 2013·1 cites·24 claims
- 3566US2020079754A1Inhibitors of brutons tyrosine kinasePHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 3666US2018208643A1Antibodies against clostridium difficile toxins and uses thereofUNIV MASSACHUSETTS·Filed 2018·Application pending·0 cites
- 3765US10745364B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2019·Granted Aug 18, 2020·0 cites·18 claims
- 3864US2015030612A1Immunization against clostridium difficile diseaseSANOFI PASTEUR BIOLOGICS LLC·Filed 2014·Application pending·0 cites
- 3963US2019100505A1Inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2018·Application pending·0 cites
- 4062US2007231336A1Immunization Against Clostridium Difficile DiseaseACAMBIS INC·Filed 2007·Application pending·0 cites
- 4162US2015315266A1Human antibodies against rabies and uses thereofUNIV MASSACHUSETTS·Filed 2014·Application pending·0 cites
- 4260US2018030027A1Inhibitors of bruton's tyrosine kinasePHARMACYCLICS LLC·Filed 2017·Application pending·0 cites
- 4359US2016152694A1Antibodies against clostridium difficile toxins and uses thereofUNIV MASSACHUSETTS·Filed 2015·Application pending·0 cites
- 4457US2006029608A1Immunization against clostridium difficile diseaseTHOMAS WILLIAM D JR·Filed 2005·Application pending·0 cites
- 4556US8835468B2N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl) arylsulfonamidesCHARVAT TREVOR T·Filed 2012·Granted Sep 16, 2014·0 cites·42 claims
- 4656US2013039926A1Human antibodies against rabies and uses thereofCT FOR DISEASE CONTROL AND PREVENTION·Filed 2012·Application pending·0 cites
- 4756US2016287689A1Immunization against clostridium difficile diseaseSANOFI PASTEUR BIOLOGICS LLC·Filed 2016·Application pending·0 cites
- 4855US5985631AMethod for preventing the activation of inactive, recombinant Helicobacter pylori apoureaseORAVAX MERIEUX CO·Filed 1997·Granted Nov 16, 1999·15 cites·4 claims
- 4953US8198309B2N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl)hetaryl arylsulfonamidesCHARVAT TREVOR T·Filed 2010·Granted Jun 12, 2012·0 cites·26 claims
- 5051US7671069B2Tricyclic, heteroaromatic compounds modulating CXCR4 and/ or CXCR7CHEMOCENTRYX INC·Filed 2007·Granted Mar 2, 2010·0 cites·11 claims
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →